Cargando…

State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer

Gastric cancer (GC) is a complex and heterogeneous disease with poor prognosis and limited available treatment options. During recent years, several molecular stratifications have been proposed to optimize the overall treatment strategy for GC patients. Breakthroughs in cancer biology and in molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basile, Debora, Simionato, Francesca, Cappetta, Alessandro, Garattini, Silvio Ken, Roviello, Giandomenico, Aprile, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572727/ https://www.ncbi.nlm.nih.gov/pubmed/34764633 http://dx.doi.org/10.2147/BTT.S290323

Ejemplares similares

An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next
por: D’Angelo, Alberto, et al.
Publicado: (2022)

Molecular classifications of gastric cancers: Novel insights and possible future applications
por: Garattini, Silvio Ken, et al.
Publicado: (2017)

Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives
por: Bobrowicz, Malgorzata, et al.
Publicado: (2019)

Precision medicine and monoclonal antibodies: breach of promise?
por: Garattini, Livio, et al.
Publicado: (2019)

Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
por: Motta, Giulia, et al.
Publicado: (2010)

Human(ized) monoclonal antibodies in atopic patients – state of the art
por: YALCIN, ARZU DIDEM, et al.
Publicado: (2020)

The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
por: Griggs, J, et al.
Publicado: (2009)

Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas
por: Catalano, Martina, et al.
Publicado: (2021)

The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer
por: Catalano, Martina, et al.
Publicado: (2022)

Second line of treatment for HER2-positive gastric cancer: an evolving issue
por: Roviello, Giandomenico, et al.
Publicado: (2021)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
por: Rosati, Gerardo, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
por: Roviello, Giandomenico, et al.
Publicado: (2021)

Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice
por: Hebert, Wesley, et al.
Publicado: (2020)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2020)

Case Report: A Metabolic Complete Response to Upfront Osimertinib in a Smoker Non-Small Cell Lung Cancer Patient Harbouring EGFR G719A/V769M Complex Mutation
por: Simionato, Francesca, et al.
Publicado: (2020)

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy
por: Sobhani, Navid, et al.
Publicado: (2017)

A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
por: Beeg, Marten, et al.
Publicado: (2019)

The distinctive nature of adenocarcinoma of the lung
por: Roviello, Giandomenico
Publicado: (2015)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights
por: Roviello, Giandomenico, et al.
Publicado: (2019)

Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?
por: Kaźmierczak-Siedlecka, Karolina, et al.
Publicado: (2021)

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022)

Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review
por: Mazurek, Marek, et al.
Publicado: (2022)

Hypersensitivity Reactions to Monoclonal Antibodies in Children
por: Mori, Francesca, et al.
Publicado: (2020)

Treatments for NAFLD: State of Art
por: Mantovani, Alessandro, et al.
Publicado: (2021)

The Role of Surgery in the Management of Gastric Cancer: State of the Art
por: Rosa, Fausto, et al.
Publicado: (2022)

The Treatment of Peritoneal Carcinomatosis in Advanced Gastric Cancer: State of the Art
por: Montori, Giulia, et al.
Publicado: (2014)

Surgical treatment of liver metastases of gastric cancer: state of the art
por: Romano, Fabrizio, et al.
Publicado: (2012)

Gastric and colonic metastasis from NSCLC: A very unusual case report
por: Catalano, Martina, et al.
Publicado: (2022)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside
por: Basile, Debora, et al.
Publicado: (2019)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Garattini, Silvio Ken, et al.
Publicado: (2021)

The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study
por: Roviello, Giandomenico, et al.
Publicado: (2019)

Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
por: Specchia, Maria Lucia, et al.
Publicado: (2014)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer
por: Roviello, Giandomenico, et al.
Publicado: (2018)

Assessment of geographic access to monoclonal antibodies in the United States
por: Rader, Benjamin, et al.
Publicado: (2022)

Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon
por: Manti, Sara, et al.
Publicado: (2021)

Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing
por: Lavacchi, Daniele, et al.
Publicado: (2023)

Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h85kgitp8gu0phri3e52adgf6o